These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 5378156)
21. [Effectiveness in vivo of some antiblastomic preparations in relation to cells resistant to bruneomycin and olivomycin]. Prokhorova EV Antibiotiki; 1969 Jun; 14(7):621-6. PubMed ID: 4185522 [No Abstract] [Full Text] [Related]
22. Modification of olivomycin A at the side chain of the aglycon yields the derivative with perspective antitumor characteristics. Tevyashova AN; Shtil AA; Olsufyeva EN; Luzikov YN; Reznikova MI; Dezhenkova LG; Isakova EB; Bukhman VM; Durandin NA; Vinogradov AM; Kuzmin VA; Preobrazhenskaya MN Bioorg Med Chem; 2011 Dec; 19(24):7387-93. PubMed ID: 22088308 [TBL] [Abstract][Full Text] [Related]
23. PRODUCTION AND THE MECHANISM OF ACTION OF OLIVOMYCIN, AN ANTITUMOUR ANTIBIOTIC. GAUSE GF; UCHOLINA RS; SVESHNIKOVA MA Acta Unio Int Contra Cancrum; 1964; 20():284-5. PubMed ID: 14151908 [No Abstract] [Full Text] [Related]
24. [Study of the antineoplastic effect of lienomycin in animal experiments]. Shorin VA; Rossolimo OK; Bazhanov VS; Averbukh LA; Kriàtova GA Antibiotiki; 1971; 16(8):708-13. PubMed ID: 5171847 [No Abstract] [Full Text] [Related]
25. [Method of determination of cumulative properties of drugs]. Gol'dberg LE; Baumshteĭn VE Farmakol Toksikol; 1969; 32(2):222-6. PubMed ID: 5772152 [No Abstract] [Full Text] [Related]
26. Reaction of the antitumor antibiotic olivomycin I with aryl diazonium salts. Synthesis, cytotoxic and antiretroviral potency of 5-aryldiazenyl-6-O-deglycosyl derivatives of olivomycin I. Tevyashova AN; Olsufyeva EN; Turchin KF; Balzarini J; Bykov EE; Dezhenkova LG; Shtil AA; Preobrazhenskaya MN Bioorg Med Chem; 2009 Jul; 17(14):4961-7. PubMed ID: 19535252 [TBL] [Abstract][Full Text] [Related]
27. Chromomycin, mithramycin, and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA)iron(II). Van Dyke MW; Dervan PB Biochemistry; 1983 May; 22(10):2373-7. PubMed ID: 6222762 [TBL] [Abstract][Full Text] [Related]
28. [Effect of antineoplastic antibiotics on resistance to bacterial infections of animals with transplanted lymphadenosis NK-LI]. Shapovalova SP Antibiotiki; 1972 Apr; 17(4):339-43. PubMed ID: 4559319 [No Abstract] [Full Text] [Related]
29. [Data on toxicity and various therapeutic results of antineoplastic antibiotics in the dog]. Stein E Tierarztl Prax; 1973; 1(1):445-56. PubMed ID: 4142522 [No Abstract] [Full Text] [Related]
30. [Antineoplastic effect of the antibiotics rubomycin B and C in experimental conditions]. Shorin VA; Rossolimo OK; Sokolov IK Antibiotiki; 1969; 14(3):249-54. PubMed ID: 5409250 [No Abstract] [Full Text] [Related]
31. [Myeloinhibitory effect of the action of some antitumor antibiotics and its comparative assessment]. Antipov IG; Novitskiĭ VV; Gol'dberg ED Antibiotiki; 1975 Oct; 20(10):897-902. PubMed ID: 1211886 [TBL] [Abstract][Full Text] [Related]
32. [Effect of olivomycin and bruneomycin and their combined use with prodigiozan on some nonspecific defense reactions of the host organism of transplanted lymphadenosis NK-LI]. Shapovalova SP Antibiotiki; 1970 Oct; 15(10):924-8. PubMed ID: 4924376 [No Abstract] [Full Text] [Related]
33. [USE OF THE ANTINEOPLASTIC ANTIBIOTICS OLIVOMYCIN (16749) AND 6613 IN THE TREATMENT OF LEUKEMIAS]. KAVERZNEVA MM Probl Gematol Pereliv Krovi; 1963 Aug; 8():22-5. PubMed ID: 14091613 [No Abstract] [Full Text] [Related]
34. [Experimental study of antitumor activity of the antibiotic bruneomycin]. Shorin VA; Rossolimo OK; Stanislavskaia MS; Pevzner NS; Shapovalova SP; Lepeshkina GN Antibiotiki; 1966 Aug; 11(8):683-91. PubMed ID: 6014957 [No Abstract] [Full Text] [Related]
35. [Effect of the diuretic diacarb on the antitumor activity of the antibiotics rubomycin and olivomycin]. Stepanova ES Antibiotiki; 1975 Apr; 20(4):300-3. PubMed ID: 1243242 [TBL] [Abstract][Full Text] [Related]
36. Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity. Tevyashova AN; Olsufyeva EN; Balzarini J; Shtil AA; Dezhenkova LG; Bukhman VM; Zbarsky VB; Preobrazhenskaya MN J Antibiot (Tokyo); 2009 Jan; 62(1):37-41. PubMed ID: 19132061 [TBL] [Abstract][Full Text] [Related]